Latest Breaking News On - General medical oncology - Page 1 : comparemela.com

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Region flamandeUnited statesHelena batesAgnieszka wozniakDominik mumbergChao chi wangMichael pehlHana malikPernille barkholtChe jui leeCarmel lynchLars henning engelholmMary clarkKu leuven cancer instituteNovo holdingsAmerican association for cancer research

BI 907828 Demonstrates Early Efficacy, Safety in MDM2-amplified Dedifferentiated Liposarcoma

The oral MDM2/p53 antagonist BI 907828 elicited preliminary antitumor activity and had a manageable safety profile in patients with MDM2-amplified dedifferentiated liposarcoma.

Region flamandePatrick schoffskiActa biochim biophysUniversity hospitals leuvenBoehringer ingelheimRare cancers congressOncology at leuven cancer instituteRare cancersGeneral medical oncologyLeuven cancer instituteSartar therapeuticsEllipses pharmaMerck healthcareBiochim biophys sinSarcomas tgct2023 esmo sarcoma and rare cancers congress

Nouscom s Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced interim data from.

Eleanor perkinPrnewswire nouscomRick davisOliver bechterSylvie berrebiBristol myers squibbSven gogovSociety for immunotherapy of cancerLeuven cancer institute belgiumJanssen research developmentAnnual meetingPrincipal investigatorGeneral medical oncologyLeuven cancer instituteChief medical officerPresentation details

Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer s 36th Annual Meeting

Milwaukee, WI (PRWEB) November 01, 2021 The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2021,

University of california irvineUnited statesUniversity hospitalJohnm kirkwoodMehmet altanPatrick danaherTianhong liKima reissOsamae rahmaPatrick hwuJames burkeEnkhtaivan gansukhUniversitario gregorio maraMartin wermkeWenliang dongDy laberiano